We are live on
!
Find out more
NanoViricides
NNVC
NNVC
51 hedge funds and large institutions have $5.47M invested in NanoViricides in 2016 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.05% less ownership
Funds ownership: 0.38% → 0.33% (-0.05%)
7% less funds holding
Funds holding: 55 → 51 (-4)
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
35% less capital invested
Capital invested by funds: $8.46M → $5.47M (-$2.99M)
45% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 11
Holders
51
Holders Change
-4
Holders Change %
-7.27%
% of All Funds
1.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
6
Reduced
11
Closed
14
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$21K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$116K |
| 2 |
ARTA
A.R.T. Advisors
New York
|
+$96.6K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$56.9K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$39.1K |
| 5 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
+$29.7K |
Top Sellers
| 1 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$505K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$218K |
| 3 |
SCM
Segantii Capital Management
Hong Kong
|
-$183K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$178K |
| 5 |
Goldman Sachs
New York
|
-$150K |
